Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research

Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies, observational in design, appear to use biased methods that can distort the interaction between RAAS inhibitor use and COVID‐19 risk. This study assessed the extent of bias in that research and reevaluated RAAS inhibit...

Descrición completa

Detalles Bibliográficos

Principais autores:	Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2022-06-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Assuntos:	angiotensin receptor blockers angiotensin‐converting enzyme inhibitors calcium channel blockers COVID‐19 renin‐aldosterone angiotensin system inhibitors thiazide diuretics
Acceso en liña:	https://www.ahajournals.org/doi/10.1161/JAHA.122.025289
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!